bmiMD Sermorelin review

An injection program that can be compared concretely

bmiMD’s sermorelin injection page describes a home-treatment package with a provider visit, injection kit and ongoing messaging. It identifies a 5 mL vial at 2 mg/mL, or 10 mg total. ^[1] Those details make the offer more useful than a general hormone-support subscription whose actual contents appear only after purchase.

I would consider this program for a reader who already has a reason to discuss sermorelin with a clinician and wants a clearly described remote service. I would be less comfortable choosing it because a longer plan looks inexpensive. The clinical purpose and the commitment deserve equal attention, particularly when the purchase involves several prepaid months.

This review concerns the injection, not every route in the catalog

bmiMD lists sermorelin tablets and nasal spray separately from injections. ^[1] Keep those preparations separate when comparing cost and evidence. A familiar ingredient name does not make different routes interchangeable, and a preference about needles should not be mistaken for proof that two products deliver the same clinical result.

The official help article says an independent licensed provider determines medical necessity and sets the injection schedule. It also distinguishes bmiMD’s technology platform from the medical service and says compounded medications are not FDA-approved. ^[2] That is useful context for a prospective patient: ask the prescriber about the clinical proposal and the pharmacy about the supplied preparation, rather than assuming the storefront itself makes every medical decision.

Read our oral sermorelin evidence guide for the next part of the decision.

The lowest monthly figure requires a longer payment

The injection page shows $139 for one month, $357 for three months and $594 for six months. The latter two correspond to $119 and $99 per allocated month, with the cards identifying three- and six-month billing intervals. ^[1] These are observed product-page offers, subject to the selected checkout agreement.

The six-month figure therefore should not be read as a flexible $99 monthly subscription. Compare how much is due now, how many shipments the term includes and what renews at the end. For an uncertain personal response, the shorter arrangement may have a financial advantage even when its allocated monthly price is higher. That flexibility is part of value rather than an inconvenience to ignore in pursuit of the lowest headline number.

The intake is already a financial decision

The refund policy distinguishes clinical ineligibility from voluntary cancellation. It says an authorization hold is released if treatment is not approved, while canceling after submitting intake incurs a nonrefundable $100 processing fee. ^[3] Resolve basic product, location and payment questions before treating submission as a no-consequence way to explore the service.

That distinction matters because the product page’s eligibility refund language can sound broader than the policy actually is. A clinician declining treatment is different from a customer changing their mind. I would keep a copy of the selected agreement and clarify how the authorization hold appears before paying. The goal is an understandable commitment from the outset, with no need to infer financial protection from a reassuring banner.

Follow-up should test the treatment purpose

The product page describes unlimited provider messaging, refill arrangements and ongoing support. ^[1] Those are practical strengths if the patient knows how to reach the clinical team and what review occurs before continuation. Ask who interprets relevant results and whether any required testing creates an additional cost.

The clinical discussion should define a realistic aim rather than presume better sleep, recovery or body composition from a product description. Adult GH-deficiency guidance concerns a diagnostic and individualized treatment setting, usually requiring stimulation testing for confirmation. ^[4] It does not establish general wellness benefits from this commercial sermorelin program. A clear explanation of why treatment is being considered is more useful than promising that stimulation of a natural pathway makes the decision straightforward.

Read our adult sermorelin research review for the next part of the decision.

Set the cancellation reminder before the renewal date

bmiMD requires pausing or cancellation by 11:59 p.m. Eastern at least seven days before renewal to stop the next cycle. Multi-month plans are prepaid, and voluntary cancellation after the initial order reaches the pharmacy does not ordinarily refund the remaining commitment. The policy provides separate provisions for documented medical cancellations. ^[3]

For a buyer, cancellation therefore has two meanings: ending future automatic renewal and recovering money already committed to the current term. Those should be assessed separately. I would choose bmiMD only if the shorter or longer agreement remains acceptable under those conditions. Its detailed injection package and messaging access are reasons to compare it seriously; the advance deadline and prepaid refund limits are reasons to choose the term deliberately, with clinical uncertainty and financial flexibility kept in view.

Read our CoreAge versus AgelessRx service comparison for the next part of the decision.

Understanding the cost

The injection page lists $139 for one month, $357 for three months and $594 for six months. The longer terms equal $119 and $99 per month but require the stated multi-month payment. Confirm the selected checkout and renewal rate. Cancellation after intake submission carries a $100 nonrefundable fee. To stop renewal, cancel by 11:59 p.m. Eastern at least seven days before the renewal date. Prepaid-term refund limits apply after the initial pharmacy order, with separate medical-cancellation provisions. ^{[1] [3]}